Florida Cancer Specialists & Research Institute | Strategic Alliance Partners

Expert panelists share their perspectives on best strategies to risk stratify patients diagnosed with cutaneous squamous cell carcinoma.

A television commercial produced by Florida Cancer Specialists & Research Institute, LLC has been recognized with a Silver ADDY® by the American Advertising Awards, which honors excellence in advertising as judged by creative industry professionals around the world.

A review of current staging systems used to categorize CSCC, particularly those from the American Joint Committee on Cancer and Brigham and Women's Hospital.

Opening their discussion on resectable cutaneous squamous cell carcinoma (CSCC), expert panelists elucidate its current incidence and known risk factors.

Florida Cancer Specialists & Research Institute, LLC, a consistent top performer among the 126 U.S.-based oncology practices that participated in the Center for Medicare & Medicaid Innovation Oncology Care Model, shares its results in the payment and delivery model’s final wave which ended in June 2022 in a newly released case study.

A recently published study in the New England Journal of Medicine provides further data to support that certain female patients over age 65 can achieve positive outcomes without postoperative radiation.

Drs Khushalani, Dietrich, Luke, and Patel discuss the nuances of defining resectability in cutaneous squamous cell carcinoma, the evolving treatment paradigm of resectable disease, and how to translate updated data with cemiplimab into clinical practice.

Florida Cancer Specialists & Research Institute has appointed Sachin Kamath, MD as Chairman of the FCS Executive Board Compliance Committee.

Florida Cancer Specialists & Research Institute, LLC is pleased to announce that Hitesh Patel, MD has joined its Executive Board, effective January 27, 2023.

Martin Dietrich, MD, PhD, and Meghan J. Mooradian, MD, conclude their discussion by discussing how they address treatment toxicity in NSCLC.

Expert oncologists look to the future of the NSCLC treatment landscape and discuss unmet needs and promising therapies.

Meghan J. Mooradian, MD, shares her approach to communicating with patients with NSCLC regarding treatment decisions based on molecular biomarkers.

Takeaways from the CheckMate 9LA, CheckMate 227, and POSEIDON trials focused on immunotherapy in non–small cell lung cancer.

Meghan J. Mooradian, MD, discusses how she makes NSCLC treatment decisions based on concurrent mutations.

Florida Cancer Specialists & Research Institute, LLC welcomes Robert Ferdman, MD to the statewide practice.

Long-serving pharmacy executive, Ray Bailey, retired on December 31, 2022.

Florida Cancer Specialists & Research Institute, LLC welcomes Board-certified medical oncologist/hematologist Madhu Unnikrishnan, MD to the statewide practice.

Florida Cancer Specialists & Research Institute, LLC takes exception to a recent study published in the New England Journal of Medicine suggesting that colonoscopies are not as effective at preventing colorectal cancer deaths as previously thought.

Lucio Gordan, MD, chief medical officer of Therapeutics & Analytics for Florida Cancer Specialists & Research Institute, is a featured speaker at the Illumina Genomics Forum in San Diego.

Florida Cancer Specialists & Research Institute, LLC celebrated the groundbreaking for a new cancer center in Wesley Chapel at 30142 State Road 56, Wesley Chapel, Florida 33543.

Florida Cancer Specialists & Research Institute, LLC is pleased to announce that Board-certified medical oncologist and hematologist Monique Sajjad, DO, a hospitalist with the statewide practice since 2018, is now providing care to patients at the Florida Cancer Specialists & Research Institute Largo Diagnostic Clinic, located at 1301 2nd Ave. SW, Suite 290, Largo, FL 33770.

Florida Cancer Specialists & Research Institute, LLC celebrated the addition of genomic testing capabilities at its Next Generation Sequencing laboratory in Fort Myers last week with a ribbon cutting ceremony.

Florida Cancer Specialists & Research Institute, LLC held a ribbon-cutting ceremony on August 18, 2022 to celebrate the opening of its newest clinical site in Pasco County.

Florida Cancer Specialists & Research Institute welcomes Board-certified hematologist/oncologist Shivtaj Mann, DO, to the statewide practice.

Florida Cancer Specialists & Research Institute announced the formation of additional precision oncology capabilities and resources comprised of geneticists, informatics specialists, and database technologies that will enhance patient care through comprehensive analysis of molecular data.

Florida Cancer Specialists & Research Institute is pleased to welcome Jon Meyers, Nicole Radford, FACHE, MS, MT(ASCP), Bob Simon, Paul D. Summitt, and Samantha Watkins to its senior management team.

New cancer treatment therapies, technologies and innovations continue to be discovered and approved for use at a rapid pace, creating an education challenge for physicians and other healthcare professionals within the complex oncology landscape.

Florida Cancer Specialists & Research Institute, LLC welcomes Board-certified medical oncologist Susanna Gaikazian, MD to the statewide practice.

Florida Cancer Specialists & Research Institute welcomes medical oncologist Mariuxi Viteri Malone, MD, to the statewide practice.

Florida Cancer Specialists & Research Institute, LLC is pleased to welcome Alexander Philipovskiy, MD, PhD, as a principal investigator at the Florida Cancer Specialists & Research Institute Drug Development Unit.